nivolumab

Explore academic connections and research related to this keyword

274
Views
13
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysis.
El-Osta, Hazem E;Mott, Frank E;Burt, Bryan M;Wang, Daniel Y;Sabichi, Anita L;
2019 oncoimmunology DOI: 10.1080/2162402X.201... 264 views
2
seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
;Catherine A. Gao;Urs M. Weber;Aldo J. Peixoto;Sarah A. Weiss
2019 journal of radiological protection : official jour... DOI: 10.1186/s40425-019-0... 384 views
3
severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non‐small cell lung cancer harboring egfr mutation
;Ou Yamaguchi;Kyoichi Kaira;Tomonori Kawasaki;Atsuto Mouri;Kosuke Hashimoto;Ayako Shiono;Shun Shinom...
2020 humanistica lovaniensia DOI: 10.1111/1759-7714.13... 221 views
4
sequential therapy with nivolumab followed by ipilimumab induces complete response in metastatic melanoma of the lung but with severe hepatotoxicities
;Sadanori Furudate;Taku Fujimura;Yumi Kambayashi;Takanori Hidaka;Akira Hashimoto;Setsuya Aiba
2016 multi-span large bridges - proceedings of the inte... DOI: 10.1159/000450974 179 views
5
development of hemolytic anemia in a nivolumab-treated patient with refractory metastatic squamous cell skin cancer and chronic lymphatic leukemia
;K.S. Schwab;A. Heine;T. Weimann;G. Kristiansen;P. Brossart
2016 multi-span large bridges - proceedings of the inte... DOI: 10.1159/000447508 214 views
6
the efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials
;Huang J;Zhang Y;Sheng J;Zhang H;Fang W;Zhan J;Zhou T;Chen Y;Liu L;Zhang L
2016 jurnal tam 204 views
7
evolving role of immunotherapy in head-and-neck cancers: a systemic review
;Raajit Chanana;Vanita Noronha;Amit Joshi;Vijay Patil;Kumar Prabhash
2018 open chemistry DOI: 10.4103/jhnps.jhnps_... 274 views
8
Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors
Shifaa M. Abdin;Dana M. Zaher;El-Shaimaa A. Arafa;Hany A. Omar;Abdin, Shifaa M.;Zaher, Dana M.;Arafa...
2018 Cancers DOI: 10.3390/cancers10020... 223 views
9
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Bekoz, Huseyin;Ozbalak, Murat;Karadurmus, Nuri;Paydas, Semra;Turker, Alev;Toptas, Tayfur;Tuglular, T...
2020 Annals of hematology DOI: 10.1007/s00277-020-0... 164 views
10
Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy.
Biniakewitz, Matthew D;Kasler, Mary Kate;Fessele, Kristen L;
Asia-Pacific journal of oncology nursing DOI: 10.4103/apjon.apjon_... 187 views

Related Journals

Asia-Pacific journal of oncology nursing
ISSN: 2347-5625 769 views
oncoimmunology
ISSN: 2162-4011 422 views
Annals of hematology
ISSN: 1432-0584 505 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

Biomarker immune checkpoint inhibitors atezolizumab lung cancer and pembrolizumab autoimmune Oncology including cancer and carcinogens tumors hepatotoxicity immune checkpoint inhibitor immune-related adverse event squamous cell carcinoma non-small cell lung cancer non-small cell lung cancer (nsclc) pd-1 neutrophil-to-lymphocyte ratio platelet-to-lymphocyte ratio brain metastases microrna-21 nsclc